{"id":"https://openalex.org/W2897698963","doi":"https://doi.org/10.1161/strokeaha.118.021990","title":"Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non\u2013Vitamin K Antagonist Oral Anticoagulants: The Stockholm Experience","display_name":"Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non\u2013Vitamin K Antagonist Oral Anticoagulants: The Stockholm Experience","alternate_titles":[],"publication_year":2018,"publication_date":"2018-09-01","ids":{"openalex":"https://openalex.org/W2897698963","doi":"https://doi.org/10.1161/strokeaha.118.021990","mag":"2897698963","pmid":"https://pubmed.ncbi.nlm.nih.gov/30354995"},"language":"en","primary_location":{"id":"doi:10.1161/strokeaha.118.021990","doi":"https://doi.org/10.1161/strokeaha.118.021990","is_oa":true,"landing_page_url":"https://doi.org/10.1161/strokeaha.118.021990","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.118.021990","source":{"id":"https://openalex.org/S62532593","display_name":"Stroke","issn_l":"0039-2499","issn":["0039-2499","1524-4628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2897698963"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.118.021990","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082184220","display_name":"Tomas Forslund","orcid":"https://orcid.org/0000-0002-2001-7710","observed_orcids":["https://orcid.org/0000-0002-2001-7710"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I2801939835","display_name":"Region Stockholm","ror":"https://ror.org/02zrae794","country_code":"SE","type":"government","lineage":["https://openalex.org/I2801939835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["DK","NL","SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Tomas Forslund","raw_affiliation_strings":["From the Clinical Pharmacology Unit, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (T.F., B.W., M.v.E., P.H.)","Stockholm County Council, Department of Healthcare Development, Sweden (T.F., B.W.)","); Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands","Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (M.A.); Department of Clinical Science and Education,","Karolinska Institute,","Karolinska University Hospital, Stockholm, Sweden (F.B","Munich, Germany","Stockholm County Council, Department of Healthcare Development, Box 6909, 10239 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Clinical Pharmacology Unit, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (T.F., B.W., M.v.E., P.H.)","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Stockholm County Council, Department of Healthcare Development, Sweden (T.F., B.W.)","institution_ids":["https://openalex.org/I2801939835"]},{"raw_affiliation_string":"); Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (M.A.); Department of Clinical Science and Education,","institution_ids":["https://openalex.org/I124055696"]},{"raw_affiliation_string":"Karolinska Institute,","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Karolinska University Hospital, Stockholm, Sweden (F.B","institution_ids":["https://openalex.org/I1335113835"]},{"raw_affiliation_string":"Munich, Germany","institution_ids":[]},{"raw_affiliation_string":"Stockholm County Council, Department of Healthcare Development, Box 6909, 10239 Stockholm, Sweden","institution_ids":["https://openalex.org/I2801939835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086973074","display_name":"Joris J. Komen","orcid":"https://orcid.org/0000-0002-5471-3132","observed_orcids":["https://orcid.org/0000-0002-5471-3132"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joris J. Komen","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands (J.J.K., A.K.M.-T.)","Joris J. Komen Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands (J.J.K., A.K.M.-T.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands (J.J.K., A.K.M.-T.)","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Joris J. Komen Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands (J.J.K., A.K.M.-T.)","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003383445","display_name":"Morten Tolstrup Andersen","orcid":"https://orcid.org/0000-0001-7029-2860","observed_orcids":["https://orcid.org/0000-0001-7029-2860"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Morten Andersen","raw_affiliation_strings":["Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (M.A.)","Morten Andersen Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (M.A.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (M.A.)","institution_ids":["https://openalex.org/I124055696"]},{"raw_affiliation_string":"Morten Andersen Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (M.A.)","institution_ids":["https://openalex.org/I124055696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023766989","display_name":"Bj\u00f6rn Wettermark","orcid":"https://orcid.org/0000-0003-0531-2516","observed_orcids":["https://orcid.org/0000-0003-0531-2516"]},"institutions":[{"id":"https://openalex.org/I2801939835","display_name":"Region Stockholm","ror":"https://ror.org/02zrae794","country_code":"SE","type":"government","lineage":["https://openalex.org/I2801939835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bj\u00f6rn Wettermark","raw_affiliation_strings":["From the Clinical Pharmacology Unit, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (T.F., B.W., M.v.E., P.H.)","Stockholm County Council, Department of Healthcare Development, Sweden (T.F., B.W.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Clinical Pharmacology Unit, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (T.F., B.W., M.v.E., P.H.)","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Stockholm County Council, Department of Healthcare Development, Sweden (T.F., B.W.)","institution_ids":["https://openalex.org/I2801939835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004494323","display_name":"Mia von Euler","orcid":"https://orcid.org/0000-0002-3845-8100","observed_orcids":["https://orcid.org/0000-0002-3845-8100"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210094988","display_name":"Stockholm South General Hospital","ror":"https://ror.org/00ncfk576","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210094988"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mia von Euler","raw_affiliation_strings":["Department of Clinical Science and Education, Karolinska Institutet Stroke Research Network at S\u00f6dersjukhuset, Stockholm, Sweden (M.v.E.)","From the Clinical Pharmacology Unit, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (T.F., B.W., M.v.E., P.H.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Science and Education, Karolinska Institutet Stroke Research Network at S\u00f6dersjukhuset, Stockholm, Sweden (M.v.E.)","institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"]},{"raw_affiliation_string":"From the Clinical Pharmacology Unit, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (T.F., B.W., M.v.E., P.H.)","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041722553","display_name":"Aukje Kaija Mantel-Teeuwisse","orcid":"https://orcid.org/0000-0002-8782-0698","observed_orcids":["https://orcid.org/0000-0002-8782-0698"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aukje K. Mantel-Teeuwisse","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands (J.J.K., A.K.M.-T.)","Aukje K. Mantel-Teeuwisse Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands (J.J.K., A.K.M.-T.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands (J.J.K., A.K.M.-T.)","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Aukje K. Mantel-Teeuwisse Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands (J.J.K., A.K.M.-T.)","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066123483","display_name":"Frieder Braunschweig","orcid":"https://orcid.org/0000-0002-4966-1315","observed_orcids":["https://orcid.org/0000-0002-4966-1315"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frieder Braunschweig","raw_affiliation_strings":["Department of Cardiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden (F.B.)","Frieder Braunschweig Department of Cardiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden (F.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden (F.B.)","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]},{"raw_affiliation_string":"Frieder Braunschweig Department of Cardiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden (F.B.)","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068373464","display_name":"Paul Hjemdahl","orcid":"https://orcid.org/0000-0001-5346-275X","observed_orcids":["https://orcid.org/0000-0001-5346-275X"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Hjemdahl","raw_affiliation_strings":["From the Clinical Pharmacology Unit, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (T.F., B.W., M.v.E., P.H.)","Paul Hjemdahl From the Clinical Pharmacology Unit, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (T.F., B.W., M.v.E., P.H.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Clinical Pharmacology Unit, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (T.F., B.W., M.v.E., P.H.)","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Paul Hjemdahl From the Clinical Pharmacology Unit, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (T.F., B.W., M.v.E., P.H.)","institution_ids":["https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5082184220"],"corresponding_institution_ids":["https://openalex.org/I124055696","https://openalex.org/I1335113835","https://openalex.org/I193662353","https://openalex.org/I2801939835","https://openalex.org/I28166907"],"apc_list":null,"apc_paid":null,"fwci":7.3538,"has_fulltext":true,"cited_by_count":84,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98057168,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"49","issue":"9","first_page":"2122","last_page":"2128"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.847000002861023},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9909999966621399},{"id":"https://openalex.org/keywords/major-bleeding","display_name":"major bleeding","score":0.9380000233650208},{"id":"https://openalex.org/keywords/anticoagulant-use","display_name":"anticoagulant use","score":0.6809999942779541},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.8859999775886536},{"id":"https://openalex.org/keywords/cha2ds2-vasc-score","display_name":"CHA2DS2-VASc score","score":0.9020000100135803},{"id":"https://openalex.org/keywords/guideline-adherence","display_name":"guideline adherence","score":0.6019999980926514},{"id":"https://openalex.org/keywords/stockholm-county","display_name":"Stockholm County","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9716118574142456},{"id":"https://openalex.org/C2776704044","wikidata":"https://www.wikidata.org/wiki/Q2852541","display_name":"Vitamin K antagonist","level":4,"score":0.8486659526824951},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.8372312188148499},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.7282237410545349},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5730562210083008},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5695821642875671},{"id":"https://openalex.org/C167704817","wikidata":"https://www.wikidata.org/wiki/Q7295548","display_name":"Rate ratio","level":3,"score":0.5679318904876709},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.5192199349403381},{"id":"https://openalex.org/C2777015399","wikidata":"https://www.wikidata.org/wiki/Q4775337","display_name":"Antithrombotic","level":2,"score":0.5026612281799316},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4896617531776428},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.1400858461856842},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1161/strokeaha.118.021990","doi":"https://doi.org/10.1161/strokeaha.118.021990","is_oa":true,"landing_page_url":"https://doi.org/10.1161/strokeaha.118.021990","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.118.021990","source":{"id":"https://openalex.org/S62532593","display_name":"Stroke","issn_l":"0039-2499","issn":["0039-2499","1524-4628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"journal-article"},{"id":"pmid:30354995","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30354995","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire/f1e1d78d-205b-4987-9056-f7b7af51771d","doi":null,"is_oa":true,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/f1e1d78d-205b-4987-9056-f7b7af51771d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Forslund, T, Komen, J J, Andersen, M, Wettermark, B, Von Euler, M, Mantel-teeuwisse, A K, Braunschweig, F & Hjemdahl, P 2018, 'Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non\u2013Vitamin K Antagonist Oral Anticoagulants : The Stockholm Experience', Stroke, vol. 49, no. 9, pp. 2122-2128. https://doi.org/10.1161/STROKEAHA.118.021990","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dspace.library.uu.nl:1874/374442","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/374442","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1161/strokeaha.118.021990","doi":"https://doi.org/10.1161/strokeaha.118.021990","is_oa":true,"landing_page_url":"https://doi.org/10.1161/strokeaha.118.021990","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.118.021990","source":{"id":"https://openalex.org/S62532593","display_name":"Stroke","issn_l":"0039-2499","issn":["0039-2499","1524-4628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G5559258887","display_name":null,"funder_award_id":"NFF15SA0018404","funder_id":"https://openalex.org/F4320325957","funder_display_name":"Novo Nordisk Fonden"}],"funders":[{"id":"https://openalex.org/F4320322570","display_name":"Stockholms L\u00e4ns Landsting","ror":"https://ror.org/02zrae794"},{"id":"https://openalex.org/F4320325957","display_name":"Novo Nordisk Fonden","ror":"https://ror.org/04txyc737"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2897698963.pdf","grobid_xml":"https://content.openalex.org/works/W2897698963.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1422496566","https://openalex.org/W1999468381","https://openalex.org/W2004592440","https://openalex.org/W2020682484","https://openalex.org/W2030466875","https://openalex.org/W2063528788","https://openalex.org/W2090544455","https://openalex.org/W2096246254","https://openalex.org/W2097854437","https://openalex.org/W2110842207","https://openalex.org/W2114775432","https://openalex.org/W2127985968","https://openalex.org/W2133435868","https://openalex.org/W2136489990","https://openalex.org/W2141761576","https://openalex.org/W2145610874","https://openalex.org/W2149388786","https://openalex.org/W2159730165","https://openalex.org/W2162508946","https://openalex.org/W2162586165","https://openalex.org/W2163427738","https://openalex.org/W2168021466","https://openalex.org/W2168545543","https://openalex.org/W2499224120","https://openalex.org/W2517864976","https://openalex.org/W2538943279","https://openalex.org/W2587690790","https://openalex.org/W2735068920","https://openalex.org/W3004050106"],"related_works":["https://openalex.org/W2955559875","https://openalex.org/W3207652198","https://openalex.org/W2760712968","https://openalex.org/W4280571488","https://openalex.org/W2767010212","https://openalex.org/W2045913143","https://openalex.org/W2063940683","https://openalex.org/W4234537519","https://openalex.org/W2296429742","https://openalex.org/W2885921390"],"abstract_inverted_index":{"Background":[0],"and":[1,34,44,50,81,147,166,241,258,279],"Purpose\u2014":[2],"The":[3,140,168,243],"purpose":[4],"of":[5,13,23,32,164,197,232,266],"this":[6],"study":[7],"was":[8,203,212,247],"to":[9,94,115,129,214,228],"investigate":[10],"the":[11,21,30,61,66,161,198,253,264],"impact":[12],"improved":[14],"antithrombotic":[15],"treatment":[16],"in":[17,36,65,127,131,143,149,154,185,249,273,276],"atrial":[18,58,274],"fibrillation":[19,59,275],"after":[20],"introduction":[22],"non\u2013vitamin":[24],"K":[25,107],"antagonist":[26,108],"oral":[27,89,109,144,207,224],"anticoagulants":[28,90,145,208,225],"on":[29],"incidence":[31,119,169],"stroke":[33,118,165,201,245,257,271],"bleeding":[35,173,190,237],"a":[37,54,188,215,229],"real-life":[38],"total":[39],"population,":[40],"including":[41],"both":[42,277],"primary":[43,278],"secondary":[45,280],"care.":[46,281],"Methods\u2014":[47],"All":[48],"resident":[49],"alive":[51],"patients":[52,155,251],"with":[53,99,187,205,252],"recorded":[55],"diagnosis":[56],"for":[57,74,88,171,219,256,270],"during":[60,77],"preceding":[62],"5":[63],"years":[64,158],"Stockholm":[67],"County":[68],"Healthcare":[69],"database":[70],"(V\u00e5rdanalysdatabasen)":[71],"were":[72,152],"followed":[73],"clinical":[75],"outcomes":[76],"2012":[78,128,240],"(n=41":[79],"008)":[80],"2017":[82,132],"(n=49":[83],"510).":[84],"Results\u2014":[85],"Pharmacy":[86],"claims":[87,111],"increased":[91,112,206],"from":[92,113,122],"51.6%":[93],"73.8%":[95],"(78.7%":[96],"among":[97],"those":[98,186],"CHA":[100],"2":[101,103],"DS":[102],"-VASc":[104],"\u22652).":[105],"Non\u2013vitamin":[106],"anticoagulant":[110],"0.4%":[114],"34.4%.":[116],"Ischemic":[117],"rates":[120,170,238],"decreased":[121,217],"2.01":[123],"per":[124],"100":[125],"person-years":[126],"1.17":[130],"(incidence":[133,177],"rate":[134,178],"ratio,":[135,179],"0.58;":[136],"95%":[137,181],"CI,":[138,182],"0.52\u20130.65).":[139],"largest":[141,244],"increases":[142],"use":[146,226],"decreases":[148],"ischemic":[150,200,233],"strokes":[151,234],"seen":[153,248],"aged":[156],"\u226580":[157],"who":[159],"had":[160],"highest":[162,254],"risk":[163,218],"bleeding.":[167,259],"major":[172],"(2.59)":[174],"remained":[175],"unchanged":[176],"1.00;":[180],"0.92\u20131.09)":[183],"even":[184],"high":[189],"risk.":[191],"Poisson":[192],"regression":[193],"showed":[194],"that":[195],"10%":[196],"absolute":[199],"reduction":[202,231,246],"associated":[204],"treatment,":[209],"whereas":[210],"27%":[211],"related":[213],"generally":[216],"all":[220],"stroke.":[221],"Conclusions\u2014":[222],"Increased":[223],"contributed":[227],"marked":[230],"without":[235],"increasing":[236],"between":[239],"2017.":[242],"elderly":[250],"risks":[255],"These":[260],"findings":[261],"strongly":[262],"support":[263],"adoption":[265],"current":[267],"guideline":[268],"recommendations":[269],"prevention":[272]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2897698963","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":18},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":19},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2018-10-26T00:00:00"}
